![](/images/general/no_picture/200_user.png)
Paul F Urrutia
Examiner (ID: 8172)
Art Unit(s) | OPLC |
Total Applications | 5 |
Issued Applications | 0 |
Pending Applications | 5 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 13125747
[patent_doc_number] => 10080788
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-25
[patent_title] => C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency
[patent_app_type] => utility
[patent_app_number] => 15/837677
[patent_app_country] => US
[patent_app_date] => 2017-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5151
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15837677
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/837677 | C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency | Dec 10, 2017 | Issued |
Array
(
[id] => 13914999
[patent_doc_number] => 10201595
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-12
[patent_title] => C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency
[patent_app_type] => utility
[patent_app_number] => 15/837969
[patent_app_country] => US
[patent_app_date] => 2017-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5149
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15837969
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/837969 | C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency | Dec 10, 2017 | Issued |
Array
(
[id] => 15083675
[patent_doc_number] => 20190336648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => BONE-PROMOTING THERMORESPONSIVE MACROMOLECULES
[patent_app_type] => utility
[patent_app_number] => 16/468224
[patent_app_country] => US
[patent_app_date] => 2017-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5194
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16468224
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/468224 | Bone-promoting thermoresponsive macromolecules | Dec 7, 2017 | Issued |
Array
(
[id] => 17103208
[patent_doc_number] => 11123399
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-21
[patent_title] => Modulators of complement activity
[patent_app_type] => utility
[patent_app_number] => 16/466165
[patent_app_country] => US
[patent_app_date] => 2017-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 34
[patent_no_of_words] => 34980
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16466165
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/466165 | Modulators of complement activity | Dec 6, 2017 | Issued |
Array
(
[id] => 16727843
[patent_doc_number] => 20210094990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => COMPOSITIONS AND METHODS FOR INHIBITION OF FOXP3
[patent_app_type] => utility
[patent_app_number] => 16/464590
[patent_app_country] => US
[patent_app_date] => 2017-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16464590
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/464590 | COMPOSITIONS AND METHODS FOR INHIBITION OF FOXP3 | Dec 6, 2017 | Pending |
Array
(
[id] => 12259416
[patent_doc_number] => 20180078612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-22
[patent_title] => 'INTRACELLULAR DELIVERY SYSTEM AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 15/830898
[patent_app_country] => US
[patent_app_date] => 2017-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 24136
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15830898
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/830898 | INTRACELLULAR DELIVERY SYSTEM AND METHODS | Dec 3, 2017 | Abandoned |
Array
(
[id] => 13533679
[patent_doc_number] => 20180318382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => THERAPY AND KIT FOR THE PREVENTION AND TREATMENT OF CYSTIC FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 15/820962
[patent_app_country] => US
[patent_app_date] => 2017-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15820962
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/820962 | Therapy and kit for the prevention and treatment of cystic fibrosis | Nov 21, 2017 | Issued |
Array
(
[id] => 13397631
[patent_doc_number] => 20180250358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => GHRH AGONISTS FOR THE TREATMENT OF ISCHEMIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/820079
[patent_app_country] => US
[patent_app_date] => 2017-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33250
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15820079
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/820079 | GHRH agonists for the treatment of ischemic disorders | Nov 20, 2017 | Issued |
Array
(
[id] => 14836179
[patent_doc_number] => 20190276490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => METHODS FOR THE IODINATION OF BIOMOLECULES
[patent_app_type] => utility
[patent_app_number] => 16/346714
[patent_app_country] => US
[patent_app_date] => 2017-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6885
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16346714
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/346714 | Methods for the iodination of biomolecules | Oct 31, 2017 | Issued |
Array
(
[id] => 15345227
[patent_doc_number] => 20200010505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => Binding Compound and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 16/344122
[patent_app_country] => US
[patent_app_date] => 2017-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15660
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16344122
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/344122 | Binding compound and uses thereof | Oct 23, 2017 | Issued |
Array
(
[id] => 16261242
[patent_doc_number] => 10752661
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-25
[patent_title] => Chimeric inhibitor molecules of complement activation
[patent_app_type] => utility
[patent_app_number] => 15/729924
[patent_app_country] => US
[patent_app_date] => 2017-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 36785
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15729924
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/729924 | Chimeric inhibitor molecules of complement activation | Oct 10, 2017 | Issued |
Array
(
[id] => 16954918
[patent_doc_number] => 11058746
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-13
[patent_title] => Use of immunomodulatory protein from
[patent_app_type] => utility
[patent_app_number] => 15/714218
[patent_app_country] => US
[patent_app_date] => 2017-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 5
[patent_no_of_words] => 3192
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15714218
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/714218 | Use of immunomodulatory protein from | Sep 24, 2017 | Issued |
Array
(
[id] => 18301108
[patent_doc_number] => 11622994
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-11
[patent_title] => Therapy for vitiligo
[patent_app_type] => utility
[patent_app_number] => 15/714627
[patent_app_country] => US
[patent_app_date] => 2017-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8660
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15714627
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/714627 | Therapy for vitiligo | Sep 24, 2017 | Issued |
Array
(
[id] => 15360943
[patent_doc_number] => 20200016236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => TREATMENT OF AGE-RELATED MACULAR DEGENERATION
[patent_app_type] => utility
[patent_app_number] => 16/335441
[patent_app_country] => US
[patent_app_date] => 2017-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9059
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335441
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/335441 | Treatment of age-related macular degeneration | Sep 21, 2017 | Issued |
Array
(
[id] => 12641238
[patent_doc_number] => 20180105577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => ALBUMIN VARIANTS
[patent_app_type] => utility
[patent_app_number] => 15/709261
[patent_app_country] => US
[patent_app_date] => 2017-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26891
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15709261
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/709261 | ALBUMIN VARIANTS | Sep 18, 2017 | Abandoned |
Array
(
[id] => 12641235
[patent_doc_number] => 20180105576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => ALBUMIN VARIANTS
[patent_app_type] => utility
[patent_app_number] => 15/709169
[patent_app_country] => US
[patent_app_date] => 2017-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26961
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15709169
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/709169 | ALBUMIN VARIANTS | Sep 18, 2017 | Abandoned |
Array
(
[id] => 12641241
[patent_doc_number] => 20180105578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => ALBUMIN VARIANTS
[patent_app_type] => utility
[patent_app_number] => 15/709263
[patent_app_country] => US
[patent_app_date] => 2017-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 233
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15709263
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/709263 | ALBUMIN VARIANTS | Sep 18, 2017 | Abandoned |
Array
(
[id] => 12239929
[patent_doc_number] => 20180072792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'ALBUMIN VARIANTS'
[patent_app_type] => utility
[patent_app_number] => 15/709227
[patent_app_country] => US
[patent_app_date] => 2017-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 28785
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15709227
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/709227 | ALBUMIN VARIANTS | Sep 18, 2017 | Abandoned |
Array
(
[id] => 12233168
[patent_doc_number] => 20180066031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'ENZYMATICALLY-CLEAVABLE PEPTIDE AMPHIPHILES'
[patent_app_type] => utility
[patent_app_number] => 15/693739
[patent_app_country] => US
[patent_app_date] => 2017-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 15952
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15693739
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/693739 | ENZYMATICALLY-CLEAVABLE PEPTIDE AMPHIPHILES | Aug 31, 2017 | Abandoned |
Array
(
[id] => 14621813
[patent_doc_number] => 20190224274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => MIF INHIBITORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/330061
[patent_app_country] => US
[patent_app_date] => 2017-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17346
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16330061
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/330061 | MIF INHIBITORS AND METHODS OF USE THEREOF | Aug 30, 2017 | Abandoned |